Overview

The Value of Oral Micronized Progesterone in the Prevention of Spontaneous Preterm Birth

Status:
Unknown status
Trial end date:
2016-06-01
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study.
Phase:
Phase 4
Details
Lead Sponsor:
Ghamra Military Hospital
Collaborator:
Ain Shams Maternity Hospital
Treatments:
Progesterone